HomeASND • NASDAQ
add
Ascendis Pharma A/S
Previous close
$122.80
Day range
$120.02 - $124.76
Year range
$83.75 - $161.00
Market cap
7.05B USD
Avg Volume
383.80K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 137.70M | 501.42% |
Operating expense | 154.86M | -6.24% |
Net income | -86.88M | 58.11% |
Net profit margin | -63.09 | 93.04% |
Earnings per share | -1.54 | 58.38% |
EBITDA | -34.97M | 76.04% |
Effective tax rate | -7.14% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 399.44M | -45.69% |
Total assets | 825.59M | -24.24% |
Total liabilities | 971.28M | 17.53% |
Total equity | -145.70M | — |
Shares outstanding | 56.61M | — |
Price to book | -47.78 | — |
Return on assets | -10.78% | — |
Return on capital | -16.78% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -86.88M | 58.11% |
Cash from operations | -42.47M | 70.03% |
Cash from investing | 6.65M | 934.50% |
Cash from financing | -6.06M | -548.85% |
Net change in cash | -49.10M | 69.98% |
Free cash flow | -85.13M | 32.97% |
About
Founded
2006
Website
Employees
879